Goldman Sachs Starts Surface Oncology (SURF) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Evercore ISI Starts Surface Oncology (SURF) at Outperform
May 14, 2018 6:04 AM EDTEvercore ISI initiates coverage on Surface Oncology (NASDAQ: SURF) with a Outperform rating and a price target of $26.00.
Analyst Josh Schimmer said they believe SURF's approach of targeting the innate immune system as well is differentiated, and the company is developing a portfolio of... More
Cowen Starts Surface Oncology (SURF) at Outperform
May 14, 2018 5:38 AM EDTCowen initiates coverage on Surface Oncology (NASDAQ: SURF) with a Outperform rating.
Analyst Boris Peaker comments "Surface is developing several drugs against novel IO targets. Given the early stage nature of these targets, we believe that positive developments internally as well as... More
